Revvity, Inc. (RVTY) stock
RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3042% above fair value
$147.79−1.06 (-0.71%)
Close on Nov 17, 2026Market cap $16.49BP/E 70.4Yield 0.19%
Revvity ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Revvity's ebitda for the twelve months ending Jul 5, 2026 was $771.08M, down 2.7% year over year. For fiscal 2025 it was $761.98M, down 1.6% from the year before. Over ten years it grew 7.9% a year on average. The highest annual figure on record is $1.57B in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $761.98M | -1.6% |
| FY2024 | Dec 29, 2024 | $774.59M | +5.8% |
| FY2023 | Dec 31, 2023 | $732.33M | -37.4% |
| FY2022 | Jan 1, 2023 | $1.17B | -25.5% |
| FY2021 | Jan 2, 2022 | $1.57B | +46.9% |
| FY2020 | Jan 3, 2021 | $1.07B | +85.6% |
| FY2019 | Dec 29, 2019 | $576.00M | +14.2% |
| FY2018 | Dec 30, 2018 | $504.47M | +25.9% |
| FY2017 | Dec 31, 2017 | $400.62M | +1.5% |
| FY2016 | Jan 1, 2017 | $394.55M | +10.7% |
| FY2015 | Jan 3, 2016 | $356.29M | +29.3% |
| FY2014 | Dec 28, 2014 | $275.47M | -22.3% |
| FY2013 | Dec 29, 2013 | $354.67M | +55.4% |
| FY2012 | Dec 30, 2012 | $228.25M | +13.0% |
| FY2011 | Jan 1, 2012 | $202.05M | -18.1% |
| FY2010 | Jan 2, 2011 | $246.73M | +25.4% |
| FY2009 | Jan 3, 2010 | $196.71M | -12.6% |
| FY2008 | Dec 28, 2008 | $225.00M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 5, 2026 | $191.36M | -1.1% |
| Q1 FY2026 | Apr 5, 2026 | $180.94M | +6.7% |
| Q4 FY2025 | Dec 28, 2025 | $214.83M | -4.0% |
| Q3 FY2025 | Sep 28, 2025 | $183.96M | -10.6% |
| Q2 FY2025 | Jun 29, 2025 | $193.54M | +0.2% |
| Q1 FY2025 | Mar 30, 2025 | $169.65M | +11.7% |
| Q4 FY2024 | Dec 29, 2024 | $223.78M | +22.5% |
| Q3 FY2024 | Sep 29, 2024 | $205.82M | +16.0% |
| Q2 FY2024 | Jun 30, 2024 | $193.07M | +3.3% |
| Q1 FY2024 | Mar 31, 2024 | $151.92M | -17.9% |
| Q4 FY2023 | Dec 31, 2023 | $182.73M | -24.4% |
| Q3 FY2023 | Oct 1, 2023 | $177.49M | -17.6% |
| Q2 FY2023 | Jul 2, 2023 | $186.99M | -45.2% |
| Q1 FY2023 | Apr 2, 2023 | $185.13M | -50.1% |
| Q4 FY2022 | Jan 1, 2023 | $241.70M | -41.6% |
| Q3 FY2022 | Oct 2, 2022 | $215.52M | -12.8% |
| Q2 FY2022 | Jul 3, 2022 | $341.19M | -11.1% |
| Q1 FY2022 | Apr 3, 2022 | $371.29M | -29.3% |
| Q4 FY2021 | Jan 2, 2022 | $413.95M | -21.8% |
| Q3 FY2021 | Oct 3, 2021 | $247.12M | -20.4% |
| Q2 FY2021 | Jul 4, 2021 | $383.64M | +63.3% |
| Q1 FY2021 | Apr 4, 2021 | $525.20M | +398.1% |
| Q4 FY2020 | Jan 3, 2021 | $529.38M | +171.3% |
| Q3 FY2020 | Oct 4, 2020 | $310.48M | +135.2% |
| Q2 FY2020 | Jul 5, 2020 | $234.93M | +62.0% |
| Q1 FY2020 | Apr 5, 2020 | $105.44M | +1.6% |
| Q4 FY2019 | Dec 29, 2019 | $195.16M | +19.8% |
| Q3 FY2019 | Sep 29, 2019 | $131.98M | +5.3% |
| Q2 FY2019 | Jun 30, 2019 | $145.06M | +10.0% |
| Q1 FY2019 | Mar 31, 2019 | $103.80M | +23.0% |
| Q4 FY2018 | Dec 30, 2018 | $162.89M | +32.3% |
| Q3 FY2018 | Sep 30, 2018 | $125.36M | +20.5% |
| Q2 FY2018 | Jul 1, 2018 | $131.84M | +33.2% |
| Q1 FY2018 | Apr 1, 2018 | $84.39M | +13.2% |
| Q4 FY2017 | Dec 31, 2017 | $123.08M | +16.2% |
| Q3 FY2017 | Oct 1, 2017 | $104.04M | +4.0% |
| Q2 FY2017 | Jul 2, 2017 | $98.94M | – |
| Q1 FY2017 | Apr 2, 2017 | $74.56M | – |
| Q4 FY2016 | Jan 1, 2017 | $105.91M | – |
| Q3 FY2016 | Oct 2, 2016 | $100.05M | – |
See a number that looks wrong?